Build an Inve Case for ELMD → Read the full call → US$ mn · quarterly
Electromed (ELMD) earnings
Electromed earnings: last reported Tue, 25 Aug 2026, for the quarter ended Jun 2026.
Electromed earnings callsElectromed earnings calls (ELMD)
Latest concall · Q2 2026 · call held call held 25 Aug 2026
Electromed Q4 FY26 — Record Revenue and Profit Growth
What went well
- Record Q4 net revenue of $19.4 million, up 12% year-over-year.
- Record Q4 operating income of $3.8 million, representing 26% year-over-year growth.
- Record Q4 diluted earnings per share of $0.39.
What to watch
- Hospital revenue declined 29% in Q4 due to longer sales cycles and less predictability.
Performance +15.0% 1Y
1Y: $24.54 on 29 Sept 2025 → $28.23. High $46.31 (6 Jul 2026), low $23.15 (24 Feb 2026).
Quarterly results
Q2 FY26: revenue up 11.6%, net profit up 54.3% against the same quarter last year.
| Line item | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15 | 16 | 16 | 17 | 17 +15% | 19 +16% | 19 +18% | 19 +12% |
| EBITDA | 2 | 3 | 2 | 3 | 3 +38% | 4 +42% | 4 +76% | 4 +26% |
| Net profit | 1 | 2 | 2 | 2 | 2 +45% | 3 +40% | 3 +59% | 3 +54% |
How to read this
US$ million, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Balance sheet
| Year ending | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|
| Equity capital | $85.0K | $85.0K | $86.0K | $87.0K | $83.0K | $84.0K |
| Reserves | $14.92M | $15.78M | $18.79M | $23.67M | $21.18M | $28.56M |
| Total liabilities | $4.69M | $7.19M | $8.14M | $7.69M | $10.59M | $12.29M |
| Fixed assets | $3.60M | $4.57M | $5.67M | $5.17M | $4.71M | $5.21M |
| Total assets | $37.11M | $41.36M | $45.81M | $52.23M | $53.80M | $66.27M |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Insider filings
24 filings between Dec 1, 2025 and Sep 1, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$2.20M
9 sales by 3 insiders
Compensation
not trading decisions- 8
- Award — granted as compensation
- 4
- Option exercise — converted options into shares
- 3
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| SKARVAN KATHLEEN | — | $1.42M | May 15, 2026 |
| Nagel Bradley M. | — | $428.9K | Jun 4, 2026 |
| Cunniff James L. | — | $354.1K | Jun 8, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Nagel Bradley M. Chief Financial Officer | Award | 4,900 | $0 |
| Sep 1, 2026 | Cunniff James L. CEO and President | Tax withheld | 2,671 | $72.4K |
| Sep 1, 2026 | Nagel Bradley M. Chief Financial Officer | Tax withheld | 1,102 | $29.9K |
| Jun 30, 2026 | Nagel Bradley M. Chief Financial Officer | Tax withheld | 674 | $28.5K |
| Jun 8, 2026 | Cunniff James L. CEO and President | Sale | 1,026 | $38.8K |
| Jun 8, 2026 | Cunniff James L. CEO and President | Sale | 7,003 | $253.9K |
| Jun 8, 2026 | Cunniff James L. CEO and President | Option exercise | 9,700 | $167.3K |
| Jun 8, 2026 | Cunniff James L. CEO and President | Sale | 1,671 | $61.5K |
| Jun 4, 2026 | Nagel Bradley M. Chief Financial Officer | Sale | 181 | $6.7K |
| Jun 4, 2026 | Nagel Bradley M. Chief Financial Officer | Option exercise | 4,334 | $44.4K |
| Jun 4, 2026 | Nagel Bradley M. Chief Financial Officer | Option exercise | 5,267 | $56.4K |
| Jun 4, 2026 | Nagel Bradley M. Chief Financial Officer | Sale | 11,620 | $422.2K |
| May 15, 2026 | SKARVAN KATHLEEN Director | Sale | 19,032 | $670.7K |
| May 15, 2026 | SKARVAN KATHLEEN Director | Sale | 3,562 | $133.0K |
| May 15, 2026 | SKARVAN KATHLEEN Director | Option exercise | 40,000 | $152.8K |
| May 15, 2026 | SKARVAN KATHLEEN Director | Sale | 8,150 | $280.1K |
| May 15, 2026 | SKARVAN KATHLEEN Director | Sale | 9,256 | $335.6K |
| Dec 1, 2025 | Walsh Andrea M. Director | Award | 3,000 | $0 |
| Dec 1, 2025 | SKARVAN KATHLEEN Director | Award | 3,000 | $0 |
| Dec 1, 2025 | Erickson Stan K. Director | Award | 3,000 | $0 |
| Dec 1, 2025 | Tune Kathleen A Director | Award | 3,000 | $0 |
| Dec 1, 2025 | Summers Andrew Director | Award | 3,000 | $0 |
| Dec 1, 2025 | Fluet Gregory Director | Award | 3,000 | $0 |
| Dec 1, 2025 | Galatowitsch Joseph L. Director | Award | 3,000 | $0 |
| Sep 11, 2025 | Summers Andrew Director | Sale | 3,153 | $77.0K |
| Sep 10, 2025 | Summers Andrew Director | Sale | 16,203 | $407.7K |
| Sep 10, 2025 | Summers Andrew Director | Sale | 39,378 | $932.4K |
| Sep 10, 2025 | Summers Andrew Director | Sale | 6,576 | $170.6K |
| Sep 10, 2025 | Summers Andrew Director | Sale | 404 | $10.8K |
| Sep 2, 2025 | Nagel Bradley M. Chief Financial Officer | Tax withheld | 562 | $13.5K |
| Sep 2, 2025 | Nagel Bradley M. Chief Financial Officer | Award | 5,300 | $0 |
| Sep 2, 2025 | Cunniff James L. CEO and President | Award | 17,000 | $0 |
| Sep 2, 2025 | Cunniff James L. CEO and President | Tax withheld | 1,291 | $30.9K |
| Feb 24, 2025 | Summers Andrew Director | Sale | 50,751 | $1.39M |
| Feb 21, 2025 | Summers Andrew Director | Sale | 11,990 | $337.6K |
| Feb 21, 2025 | Summers Andrew Director | Sale | 11,992 | $337.7K |
| Feb 21, 2025 | Summers Andrew Director | Sale | 734 | $21.3K |
| Feb 21, 2025 | Summers Andrew Director | Sale | 735 | $21.3K |
| Feb 20, 2025 | Summers Andrew Director | Sale | 1,948 | $58.1K |
| Feb 20, 2025 | Summers Andrew Director | Sale | 15,689 | $450.4K |
| Feb 20, 2025 | Summers Andrew Director | Sale | 1,947 | $58.0K |
| Feb 20, 2025 | Summers Andrew Director | Sale | 15,689 | $450.4K |
| Feb 18, 2025 | SKARVAN KATHLEEN Director | Sale | 5,000 | $145.8K |
| Feb 18, 2025 | SKARVAN KATHLEEN Director | Sale | 38,954 | $1.14M |
| Feb 14, 2025 | SKARVAN KATHLEEN Director | Option exercise | 40,000 | $72.0K |
| Feb 14, 2025 | SKARVAN KATHLEEN Director | Tax withheld | 15,178 | $504.1K |
| Feb 14, 2025 | SKARVAN KATHLEEN Director | Sale | 7,558 | $242.8K |
| Feb 14, 2025 | SKARVAN KATHLEEN Director | Sale | 1,082 | $35.8K |
| Feb 14, 2025 | SKARVAN KATHLEEN Director | Sale | 23,989 | $769.3K |
| Dec 31, 2024 | Cunniff James L. CEO and President | Option exercise | 87,500 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.